New AAPS-RX Global Collaboration Produces 2-for-1 Registration Deal

AAPS serves as the exclusive authority on scientific focus areas that affect RX’s INTERPHEX, the approximate 8,000-person event, beginning in spring 2023. AAPS plays a key role in reviewing and selecting programming for the event, particularly in areas focused on the intersection of business and science.

AAPS collaborates with INTERPHEX to benefit members in a variety of ways. For example, in 2023 registrants of AAPS’ National Biotechnology Conference (NBC) can attend INTERPHEX free of charge.

Upon registering for NBC, attendees receive a custom link to access INTERPHEX. Instructions are included in the confirmation email.

The following video provides more information about the benefits of this partnership.

AAPS is now seeking a Chair and Vice Chair who will lead the first INTERPHEX Scientific Programming Advisory Committee.

AAPS is the exclusive authority on scientific focus areas that affect INTERPHEX. Beginning with the 2024 event, the INTERPHEX Scientific Programming Advisory Committee will review and select programming for the event, which takes place each spring in New York City.

Qualifications Include

• Must be an AAPS member at time of application and throughout service.
• Must attend INTERPHEX 2023 in New York City, April 25-27.
• Depth of expertise, preferably influence, in a pharmaceutical discipline relevant and specific to CMC and Manufacturing.

• Is consistent with the scientific focus areas most important to RX.
• Achieves the programmatic objectives of INTERPHEX.
• Ensures high standards for presentation.
• Prioritizes attendee experience over other concerns.
• Meets critical, contractually obligated deadlines and milestones

• Chair (PDF)
• Vice Chair (PDF)

Ready to apply?

Applicants will be notified about their application status in March.